Evidence map›Paper›PMID 41855227›Full record

ArticlePLoS biology2026

Pathogen host jump risk is not predicted by spillover rate, but rather by novelty.

Brandon J Simony, David A Kennedy

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Brandon J SimonyDepartment of Biology and the Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0001-8573-6401
David A KennedyDepartment of Biology and the Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0003-0820-115X

Funding

US-UK Collab: The consequences of transmissible vaccines on disease ecology and pathogen evolution: Marek's disease virus as a case studyR01GM140459 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI KENNEDY, DAVID · 2020 to 2024
$1.7M
NIGMS NIH HHS R01 GM140459
6 · The paper itself

Abstract

Host jumps-defined as the process by which a pathogen establishes sustained transmission in novel hosts-are threats to human and animal welfare, but anticipating which pathogen will be the next to successfully host jump remains elusive. A spillover event must precede a host jump, and so spillover rate is thought to be related to risk. However, nonendemic pathogens that spill over frequently have demonstrated a poor ability to host jump from any given spillover. So which is riskier, pathogens that spill over rarely or commonly? Applying a Bayesian framework to a general model of host jump risk, we show that 1) the riskiest pathogens can be those that spill over at low, intermediate, or high rates, and 2) as the rate of spillover gets large, the information gained from past spillovers is exactly counterbalanced by the increased number of future spillovers. Taken together, this means that spillover rate has little to no value in explaining host jump risk. Rather, we show that novel pathogens (i.e., pathogens with a relatively short history of spilling over in their current form) are substantially more likely to result in host jumps than pathogens that have had long-associated opportunities for spillover into the novel host. Notably, a pathogen might be thought of as novel if spillover only recently became possible, or if it recently underwent substantial evolutionary change. We therefore propose that the length of historical association, but not spillover rate, will be an important predictor of host jump risk.

Indexed as

Host-Pathogen InteractionsZoonosesAnimalsBayes TheoremHumansModels, Biological

Identifiers

PMID41855227
PMCPMC13001934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.